Jeff Geschwind, MD – Cancer Drug Innovator Founder of Cage Pharma, Jeff Geschwind, MD researches tumor metabolism-targeting drugs, particularly glycolysis inhibitors. His work paves the way for next-generation cancer therapies. https://www.linkedin.com/in/jeff-geschwind-037200174